The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
Wipro's MPPP360 platform will assist Independent Health in streamlining the payment process to seamlessly integrate these new provisions
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
The inspection was conducted from April 8 to April 12, 2024 and concluded with no observations
A game changing solution for the pharmaceutical industry
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
Under this agreement, lpca will grant to Omexa a non-exclusive right to research, develop, manufacture and market an anti-cancer biosimilar for the global market
This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
The drug will target specific genetic mutations prevalent in certain types of cancers
Subscribe To Our Newsletter & Stay Updated
